Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Verrica Pharmaceuticals Inc

$10 Million Bet On This Stock? 3 Penny Stocks Insiders are Buying

U.S. stock futures traded slightly lower this morning on Wednesday after the Nasdaq recorded sharp gains on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga · Jul 6, 2022

Analysts Still Believe Verrica's Ycanth Is Approvable Despite FDA Response Letter

Analysts Still Believe Verrica's Ycanth Is Approvable Despite FDA Response Letter

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) held a Type A meeting with the FDA regarding the path forward for the resubmission and potential approval of Ycanth (VP-102) for molluscum contagiosum. HC Wainwright says VP-102 was approvable, and at the time of the Complete Response Letter (CRL), Verrica had already engaged a potential alternate solution supplier. It reiterates…

Benzinga · Jun 29, 2022

RBC Capital Slashes Verrica's Price Target After Third Rejection - What's Next?

RBC Capital Slashes Verrica's Price Target After Third Rejection - What's Next?

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) was slapped with a third FDA rejection for YCANTH (VP-102) as general contract manufacturing organization challenges continue to plague the approval. RBC Capital Markets has downgraded the stock to Sector Perform from Outperform and lowered the price target from $16 to $4. The analysts note that the issues fall outside of…

Benzinga · May 25, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Verrica Pharma Shares Are Plunging Today

The FDA has issued a Complete Response Letter (CRL) regarding Verrica Pharmaceuticals Inc's (NASDAQ:VRCA) marketing application for VP-102 for molluscum contagiosum. The only deficiency listed in the CRL was related to the deficiencies identified at a general reinspection of Sterling Pharmaceuticals Services LLC, the contract manufacturing organization that manufactures Verrica's bulk solution drug product. …

Benzinga · May 25, 2022

1

Coverage From

Benzinga

Organisations

RBC Capital Markets

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

421,998 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play